Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87512 refers to the detection of the infectious agent Gardnerella vaginalis through nucleic acid techniques, specifically focusing on the quantification of the organism's DNA or RNA. Gardnerella vaginalis is a bacterium commonly associated with bacterial vaginosis, a condition that affects the female genital tract. This procedure utilizes advanced molecular techniques to identify the presence of Gardnerella vaginalis by measuring the amount of its nucleic acids in a sample. The quantification process is crucial as it not only confirms the presence of the bacteria but also provides valuable information regarding the severity of the infection and the effectiveness of any ongoing treatment. The testing can be performed using various methodologies, including direct probes and amplified probes, with the quantification step being particularly important for assessing the load of the infectious agent. This information is essential for healthcare providers in making informed decisions about patient management and treatment strategies.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 87512 is indicated for the detection and quantification of Gardnerella vaginalis in patients who may be experiencing symptoms related to bacterial vaginosis. The following conditions may warrant this testing:
The procedure for CPT® Code 87512 involves several key steps to ensure accurate detection and quantification of Gardnerella vaginalis. The following procedural steps are outlined:
After the completion of the procedure associated with CPT® Code 87512, the results of the quantification will be analyzed and reported. Healthcare providers will review the findings to assess the presence and load of Gardnerella vaginalis. Based on the results, further clinical decisions may be made regarding treatment options or additional testing. Patients may be advised on follow-up care, especially if the quantification indicates a significant infection that requires intervention. It is important for healthcare providers to communicate the results clearly to the patient and discuss any necessary next steps in their care plan.
| Short Descr | GARDNER VAG DNA QUANT | Medium Descr | IADNA GARDNERELLA VAGINALIS QUANTIFICATION | Long Descr | Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, quantification | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | GA | Waiver of liability statement issued as required by payer policy, individual case | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GW | Service not related to the hospice patient's terminal condition | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | GZ | Item or service expected to be denied as not reasonable and necessary | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 1998-01-01 | Added | First appearance in code book in 1998. |
Get instant expert-level medical coding assistance.